Literature DB >> 29328680

Insomnia and motor vehicle accident-related injuries, active component, U.S. Armed Forces, 2007-2016.

Elizabeth A Erickson, Shauna Stahlman, Mark G McNellis.   

Abstract

Insomnia is the most common sleep disorder in adults, and its incidence is increasing in the U.S. Armed Forces. A potential consequence of insomnia (including medications used to treat it) is increased risk of motor vehicle accidents (MVAs), which cause significant morbidity and mortality in service members. To examine the relationship between insomnia and MVA-related injuries in the U.S. Armed Forces, this retrospective cohort study compared incidence rates of MVA-related injuries from 2007 through 2016 between service members with diagnosed insomnia and an unexposed cohort. After adjustment for multiple covariates, service members with insomnia had more than double the rate of MVA-related injuries, compared to service members without insomnia (adjusted incidence rate ratio: 2.08; 95% CI: 1.95-2.22). A subanalysis of service members with insomnia during 2014-2016 found no difference in risk of MVA-related injury based on days' supply of sleep aid medications prescribed in 365 days following insomnia diagnosis. Insomnia is an important potential risk factor for MVAs in the military. Sleep health should be a component of MVA prevention efforts.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29328680

Source DB:  PubMed          Journal:  MSMR        ISSN: 2152-8217


  2 in total

1.  The risk factors for insomnia and sleep-disordered breathing in military communities: A meta-analysis.

Authors:  Yujia Huang; Jingzhou Xu; Siqi Zheng; Shuyu Xu; Yajing Wang; Jing Du; Lei Xiao; Ruike Zhang; Hao Wang; Yunxiang Tang; Tong Su
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

2.  Prevalence and Factors Associated with Insomnia in Military Personnel: A Retrospective Study during the Second COVID-19 Epidemic Wave in Peru.

Authors:  Mario J Valladares-Garrido; Cinthia Karina Picón-Reátegui; J Pierre Zila-Velasque; Pamela Grados-Espinoza
Journal:  Healthcare (Basel)       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.